nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—hematologic cancer	0.514	1	CbGaD
Cysteamine—MPO—Cisplatin—hematologic cancer	0.0496	1	CbGbCtD
Cysteamine—SST—hematopoietic system—hematologic cancer	0.00511	0.278	CbGeAlD
Cysteamine—SST—blood—hematologic cancer	0.00338	0.184	CbGeAlD
Cysteamine—MPO—hematopoietic system—hematologic cancer	0.00206	0.112	CbGeAlD
Cysteamine—SST—lymph node—hematologic cancer	0.00203	0.11	CbGeAlD
Cysteamine—MPO—blood—hematologic cancer	0.00136	0.0741	CbGeAlD
Cysteamine—MPO—bone marrow—hematologic cancer	0.00132	0.0717	CbGeAlD
Cysteamine—MPO—lung—hematologic cancer	0.00119	0.0649	CbGeAlD
Cysteamine—MPO—testis—hematologic cancer	0.00113	0.0613	CbGeAlD
Cysteamine—MPO—lymph node—hematologic cancer	0.000817	0.0444	CbGeAlD
Cysteamine—NPY2R—GPCR downstream signaling—JAK1—hematologic cancer	8.92e-05	0.000548	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAC2—hematologic cancer	8.9e-05	0.000547	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADCY7—hematologic cancer	8.87e-05	0.000545	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DKK1—hematologic cancer	8.83e-05	0.000543	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT5B—hematologic cancer	8.76e-05	0.000538	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CSF2—hematologic cancer	8.75e-05	0.000538	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2RA—hematologic cancer	8.69e-05	0.000534	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—XIAP—hematologic cancer	8.63e-05	0.00053	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADCY7—hematologic cancer	8.51e-05	0.000523	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—JAK1—hematologic cancer	8.45e-05	0.000519	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCG—hematologic cancer	8.45e-05	0.000519	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SH2B3—hematologic cancer	8.41e-05	0.000517	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SMARCA4—hematologic cancer	8.41e-05	0.000517	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CSF2—hematologic cancer	8.39e-05	0.000516	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GZMB—hematologic cancer	8.36e-05	0.000514	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2RA—hematologic cancer	8.33e-05	0.000512	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—hematologic cancer	8.29e-05	0.000509	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—XIAP—hematologic cancer	8.27e-05	0.000508	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNA1—hematologic cancer	8.16e-05	0.000501	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EIF4EBP1—hematologic cancer	8.11e-05	0.000499	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HSPB1—hematologic cancer	8.11e-05	0.000499	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL3—hematologic cancer	8.11e-05	0.000499	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—JAK1—hematologic cancer	8.1e-05	0.000498	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCG—hematologic cancer	8.1e-05	0.000498	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SH2B3—hematologic cancer	8.06e-05	0.000495	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SMARCA4—hematologic cancer	8.06e-05	0.000495	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTHLH—hematologic cancer	8.02e-05	0.000493	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SDC1—hematologic cancer	8.02e-05	0.000493	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GZMB—hematologic cancer	8.01e-05	0.000492	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2RA—hematologic cancer	7.89e-05	0.000485	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNA1—hematologic cancer	7.82e-05	0.000481	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTGER4—hematologic cancer	7.81e-05	0.00048	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EIF4EBP1—hematologic cancer	7.78e-05	0.000478	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HSPB1—hematologic cancer	7.78e-05	0.000478	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL3—hematologic cancer	7.78e-05	0.000478	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LCK—hematologic cancer	7.77e-05	0.000477	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTHLH—hematologic cancer	7.69e-05	0.000473	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SDC1—hematologic cancer	7.69e-05	0.000473	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—hematologic cancer	7.64e-05	0.00047	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—H3F3A—hematologic cancer	7.62e-05	0.000468	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2RA—hematologic cancer	7.56e-05	0.000465	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTGER4—hematologic cancer	7.49e-05	0.00046	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LCK—hematologic cancer	7.45e-05	0.000458	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCZ—hematologic cancer	7.4e-05	0.000455	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—H3F3A—hematologic cancer	7.3e-05	0.000449	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—hematologic cancer	7.24e-05	0.000445	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PARP1—hematologic cancer	7.15e-05	0.000439	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCZ—hematologic cancer	7.1e-05	0.000436	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FBXW7—hematologic cancer	7.04e-05	0.000432	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—hematologic cancer	6.94e-05	0.000426	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR4—hematologic cancer	6.9e-05	0.000424	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HDAC2—hematologic cancer	6.9e-05	0.000424	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PARP1—hematologic cancer	6.86e-05	0.000421	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FBXW7—hematologic cancer	6.75e-05	0.000414	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CBL—hematologic cancer	6.72e-05	0.000413	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL3—hematologic cancer	6.65e-05	0.000409	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR4—hematologic cancer	6.61e-05	0.000406	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HDAC2—hematologic cancer	6.61e-05	0.000406	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CG—hematologic cancer	6.57e-05	0.000404	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTPN1—hematologic cancer	6.54e-05	0.000402	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTPN11—hematologic cancer	6.46e-05	0.000397	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CBL—hematologic cancer	6.45e-05	0.000396	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RASGRP1—hematologic cancer	6.43e-05	0.000395	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SYK—hematologic cancer	6.41e-05	0.000394	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HSP90AA1—hematologic cancer	6.41e-05	0.000394	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL3—hematologic cancer	6.38e-05	0.000392	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—hematologic cancer	6.36e-05	0.000391	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—hematologic cancer	6.3e-05	0.000387	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTPN1—hematologic cancer	6.27e-05	0.000385	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CREB1—hematologic cancer	6.26e-05	0.000384	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTPN11—hematologic cancer	6.19e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT1—hematologic cancer	6.19e-05	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RASGRP1—hematologic cancer	6.17e-05	0.000379	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SYK—hematologic cancer	6.15e-05	0.000378	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HSP90AA1—hematologic cancer	6.15e-05	0.000378	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL2—hematologic cancer	6.12e-05	0.000376	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6R—hematologic cancer	6.1e-05	0.000375	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—hematologic cancer	6.1e-05	0.000375	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3R1—hematologic cancer	6.01e-05	0.000369	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CREB1—hematologic cancer	6e-05	0.000369	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT1—hematologic cancer	5.93e-05	0.000364	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—hematologic cancer	5.87e-05	0.000361	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6R—hematologic cancer	5.85e-05	0.00036	CbGpPWpGaD
Cysteamine—Nervous system disorder—Dexamethasone—hematologic cancer	5.85e-05	0.000229	CcSEcCtD
Cysteamine—Agitation—Prednisone—hematologic cancer	5.85e-05	0.000229	CcSEcCtD
Cysteamine—Dermatitis—Alitretinoin—hematologic cancer	5.85e-05	0.000229	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—JAK2—hematologic cancer	5.84e-05	0.000359	CbGpPWpGaD
Cysteamine—Vomiting—Ifosfamide—hematologic cancer	5.83e-05	0.000228	CcSEcCtD
Cysteamine—Hypersensitivity—Cisplatin—hematologic cancer	5.83e-05	0.000228	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—MAP2K1—hematologic cancer	5.82e-05	0.000357	CbGpPWpGaD
Cysteamine—Headache—Alitretinoin—hematologic cancer	5.82e-05	0.000228	CcSEcCtD
Cysteamine—Diarrhoea—Gemcitabine—hematologic cancer	5.81e-05	0.000227	CcSEcCtD
Cysteamine—Nausea—Thalidomide—hematologic cancer	5.8e-05	0.000227	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—hematologic cancer	5.79e-05	0.000227	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRB2—hematologic cancer	5.79e-05	0.000356	CbGpPWpGaD
Cysteamine—Dyspepsia—Triamcinolone—hematologic cancer	5.79e-05	0.000226	CcSEcCtD
Cysteamine—Rash—Ifosfamide—hematologic cancer	5.79e-05	0.000226	CcSEcCtD
Cysteamine—Dermatitis—Ifosfamide—hematologic cancer	5.78e-05	0.000226	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CD—hematologic cancer	5.78e-05	0.000355	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFA—hematologic cancer	5.77e-05	0.000355	CbGpPWpGaD
Cysteamine—Dizziness—Irinotecan—hematologic cancer	5.76e-05	0.000225	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3R1—hematologic cancer	5.76e-05	0.000354	CbGpPWpGaD
Cysteamine—Urticaria—Etoposide—hematologic cancer	5.76e-05	0.000225	CcSEcCtD
Cysteamine—Abdominal pain—Etoposide—hematologic cancer	5.73e-05	0.000224	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—hematologic cancer	5.73e-05	0.000224	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KITLG—hematologic cancer	5.69e-05	0.00035	CbGpPWpGaD
Cysteamine—Vomiting—Vincristine—hematologic cancer	5.69e-05	0.000223	CcSEcCtD
Cysteamine—Anorexia—Dexamethasone—hematologic cancer	5.69e-05	0.000223	CcSEcCtD
Cysteamine—Anorexia—Betamethasone—hematologic cancer	5.69e-05	0.000223	CcSEcCtD
Cysteamine—Urticaria—Prednisolone—hematologic cancer	5.68e-05	0.000222	CcSEcCtD
Cysteamine—Asthenia—Cisplatin—hematologic cancer	5.68e-05	0.000222	CcSEcCtD
Cysteamine—Fatigue—Triamcinolone—hematologic cancer	5.67e-05	0.000222	CcSEcCtD
Cysteamine—Urinary tract disorder—Epirubicin—hematologic cancer	5.65e-05	0.000221	CcSEcCtD
Cysteamine—Rash—Vincristine—hematologic cancer	5.64e-05	0.000221	CcSEcCtD
Cysteamine—Dermatitis—Vincristine—hematologic cancer	5.64e-05	0.000221	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—hematologic cancer	5.62e-05	0.00022	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—hematologic cancer	5.6e-05	0.000219	CcSEcCtD
Cysteamine—Headache—Vincristine—hematologic cancer	5.6e-05	0.000219	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—JAK2—hematologic cancer	5.6e-05	0.000344	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAP2K1—hematologic cancer	5.58e-05	0.000343	CbGpPWpGaD
Cysteamine—Nausea—Carmustine—hematologic cancer	5.57e-05	0.000218	CcSEcCtD
Cysteamine—SST—Signaling Pathways—STAT5A—hematologic cancer	5.56e-05	0.000342	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRB2—hematologic cancer	5.55e-05	0.000341	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—hematologic cancer	5.55e-05	0.000341	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—hematologic cancer	5.54e-05	0.00034	CbGpPWpGaD
Cysteamine—Vomiting—Irinotecan—hematologic cancer	5.54e-05	0.000217	CcSEcCtD
Cysteamine—Vomiting—Mitoxantrone—hematologic cancer	5.54e-05	0.000217	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDGFA—hematologic cancer	5.53e-05	0.00034	CbGpPWpGaD
Cysteamine—Immune system disorder—Methotrexate—hematologic cancer	5.52e-05	0.000216	CcSEcCtD
Cysteamine—Nausea—Alitretinoin—hematologic cancer	5.51e-05	0.000216	CcSEcCtD
Cysteamine—Convulsion—Prednisone—hematologic cancer	5.51e-05	0.000216	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CDKN2B—hematologic cancer	5.51e-05	0.000339	CbGpPWpGaD
Cysteamine—Hypertension—Prednisone—hematologic cancer	5.49e-05	0.000215	CcSEcCtD
Cysteamine—Rash—Irinotecan—hematologic cancer	5.49e-05	0.000215	CcSEcCtD
Cysteamine—Rash—Mitoxantrone—hematologic cancer	5.49e-05	0.000215	CcSEcCtD
Cysteamine—Dermatitis—Irinotecan—hematologic cancer	5.49e-05	0.000215	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—hematologic cancer	5.49e-05	0.000215	CcSEcCtD
Cysteamine—Headache—Irinotecan—hematologic cancer	5.46e-05	0.000214	CcSEcCtD
Cysteamine—Headache—Mitoxantrone—hematologic cancer	5.46e-05	0.000214	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3R1—hematologic cancer	5.46e-05	0.000335	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KITLG—hematologic cancer	5.46e-05	0.000335	CbGpPWpGaD
Cysteamine—Nausea—Ifosfamide—hematologic cancer	5.45e-05	0.000213	CcSEcCtD
Cysteamine—Feeling abnormal—Triamcinolone—hematologic cancer	5.42e-05	0.000212	CcSEcCtD
Cysteamine—Diarrhoea—Cisplatin—hematologic cancer	5.41e-05	0.000212	CcSEcCtD
Cysteamine—Vomiting—Gemcitabine—hematologic cancer	5.4e-05	0.000211	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.38e-05	0.000211	CcSEcCtD
Cysteamine—Discomfort—Prednisone—hematologic cancer	5.35e-05	0.00021	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—hematologic cancer	5.35e-05	0.00021	CcSEcCtD
Cysteamine—Rash—Gemcitabine—hematologic cancer	5.35e-05	0.000209	CcSEcCtD
Cysteamine—Dermatitis—Gemcitabine—hematologic cancer	5.35e-05	0.000209	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—hematologic cancer	5.34e-05	0.000209	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—STAT5A—hematologic cancer	5.33e-05	0.000328	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CD86—hematologic cancer	5.33e-05	0.000328	CbGpPWpGaD
Cysteamine—Malnutrition—Methotrexate—hematologic cancer	5.32e-05	0.000208	CcSEcCtD
Cysteamine—Erythema—Methotrexate—hematologic cancer	5.32e-05	0.000208	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—hematologic cancer	5.32e-05	0.000327	CbGpPWpGaD
Cysteamine—Headache—Gemcitabine—hematologic cancer	5.32e-05	0.000208	CcSEcCtD
Cysteamine—Nausea—Vincristine—hematologic cancer	5.31e-05	0.000208	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—JAK2—hematologic cancer	5.3e-05	0.000326	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN2B—hematologic cancer	5.29e-05	0.000325	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisolone—hematologic cancer	5.27e-05	0.000206	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HES1—hematologic cancer	5.26e-05	0.000323	CbGpPWpGaD
Cysteamine—Dyspepsia—Dexamethasone—hematologic cancer	5.25e-05	0.000205	CcSEcCtD
Cysteamine—Dyspepsia—Betamethasone—hematologic cancer	5.25e-05	0.000205	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3R1—hematologic cancer	5.23e-05	0.000321	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NCOR1—hematologic cancer	5.23e-05	0.000321	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Doxorubicin—hematologic cancer	5.22e-05	0.000204	CcSEcCtD
Cysteamine—Urticaria—Triamcinolone—hematologic cancer	5.22e-05	0.000204	CcSEcCtD
Cysteamine—Asthenia—Etoposide—hematologic cancer	5.2e-05	0.000204	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—hematologic cancer	5.2e-05	0.000203	CcSEcCtD
Cysteamine—Body temperature increased—Triamcinolone—hematologic cancer	5.2e-05	0.000203	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisone—hematologic cancer	5.19e-05	0.000203	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—hematologic cancer	5.19e-05	0.000203	CcSEcCtD
Cysteamine—Decreased appetite—Dexamethasone—hematologic cancer	5.18e-05	0.000203	CcSEcCtD
Cysteamine—Decreased appetite—Betamethasone—hematologic cancer	5.18e-05	0.000203	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—hematologic cancer	5.18e-05	0.000203	CcSEcCtD
Cysteamine—Nausea—Irinotecan—hematologic cancer	5.18e-05	0.000203	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF1—hematologic cancer	5.17e-05	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CSF2—hematologic cancer	5.17e-05	0.000318	CbGpPWpGaD
Cysteamine—Immune system disorder—Epirubicin—hematologic cancer	5.16e-05	0.000202	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.15e-05	0.000202	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.15e-05	0.000202	CcSEcCtD
Cysteamine—Fatigue—Dexamethasone—hematologic cancer	5.14e-05	0.000201	CcSEcCtD
Cysteamine—Fatigue—Betamethasone—hematologic cancer	5.14e-05	0.000201	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CD86—hematologic cancer	5.11e-05	0.000314	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FOXO1—hematologic cancer	5.1e-05	0.000313	CbGpPWpGaD
Cysteamine—Nervous system disorder—Prednisone—hematologic cancer	5.09e-05	0.000199	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2—hematologic cancer	5.09e-05	0.000313	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFRB—hematologic cancer	5.09e-05	0.000313	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—JAK2—hematologic cancer	5.08e-05	0.000312	CbGpPWpGaD
Cysteamine—Skin disorder—Prednisone—hematologic cancer	5.05e-05	0.000197	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HES1—hematologic cancer	5.04e-05	0.00031	CbGpPWpGaD
Cysteamine—Nausea—Gemcitabine—hematologic cancer	5.04e-05	0.000197	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CB—hematologic cancer	5.04e-05	0.000309	CbGpPWpGaD
Cysteamine—Vomiting—Cisplatin—hematologic cancer	5.03e-05	0.000197	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NCOR1—hematologic cancer	5.01e-05	0.000308	CbGpPWpGaD
Cysteamine—Mental disorder—Epirubicin—hematologic cancer	5.01e-05	0.000196	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PDGFRA—hematologic cancer	5.01e-05	0.000308	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JAK1—hematologic cancer	4.99e-05	0.000307	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCG—hematologic cancer	4.99e-05	0.000307	CbGpPWpGaD
Cysteamine—Rash—Cisplatin—hematologic cancer	4.99e-05	0.000195	CcSEcCtD
Cysteamine—Dermatitis—Cisplatin—hematologic cancer	4.98e-05	0.000195	CcSEcCtD
Cysteamine—Erythema—Epirubicin—hematologic cancer	4.98e-05	0.000195	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—hematologic cancer	4.98e-05	0.000195	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—hematologic cancer	4.96e-05	0.000194	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CSF2—hematologic cancer	4.96e-05	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF1—hematologic cancer	4.96e-05	0.000305	CbGpPWpGaD
Cysteamine—Anorexia—Prednisone—hematologic cancer	4.95e-05	0.000194	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—hematologic cancer	4.92e-05	0.000192	CcSEcCtD
Cysteamine—Feeling abnormal—Dexamethasone—hematologic cancer	4.91e-05	0.000192	CcSEcCtD
Cysteamine—Feeling abnormal—Betamethasone—hematologic cancer	4.91e-05	0.000192	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FOXO1—hematologic cancer	4.89e-05	0.0003	CbGpPWpGaD
Cysteamine—Tension—Epirubicin—hematologic cancer	4.88e-05	0.000191	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—hematologic cancer	4.88e-05	0.0003	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.88e-05	0.000191	CcSEcCtD
Cysteamine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.88e-05	0.000191	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDGFRB—hematologic cancer	4.88e-05	0.0003	CbGpPWpGaD
Cysteamine—Hypersensitivity—Triamcinolone—hematologic cancer	4.84e-05	0.00019	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—hematologic cancer	4.83e-05	0.000189	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—hematologic cancer	4.83e-05	0.000297	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDGFRA—hematologic cancer	4.8e-05	0.000295	CbGpPWpGaD
Cysteamine—Dizziness—Etoposide—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PRKCG—hematologic cancer	4.78e-05	0.000294	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JAK1—hematologic cancer	4.78e-05	0.000294	CbGpPWpGaD
Cysteamine—Immune system disorder—Doxorubicin—hematologic cancer	4.78e-05	0.000187	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—hematologic cancer	4.76e-05	0.000186	CcSEcCtD
Cysteamine—Urticaria—Dexamethasone—hematologic cancer	4.74e-05	0.000185	CcSEcCtD
Cysteamine—Urticaria—Betamethasone—hematologic cancer	4.74e-05	0.000185	CcSEcCtD
Cysteamine—Dizziness—Prednisolone—hematologic cancer	4.73e-05	0.000185	CcSEcCtD
Cysteamine—Asthenia—Triamcinolone—hematologic cancer	4.72e-05	0.000185	CcSEcCtD
Cysteamine—Abdominal pain—Betamethasone—hematologic cancer	4.71e-05	0.000185	CcSEcCtD
Cysteamine—Abdominal pain—Dexamethasone—hematologic cancer	4.71e-05	0.000185	CcSEcCtD
Cysteamine—Body temperature increased—Betamethasone—hematologic cancer	4.71e-05	0.000185	CcSEcCtD
Cysteamine—Body temperature increased—Dexamethasone—hematologic cancer	4.71e-05	0.000185	CcSEcCtD
Cysteamine—Nausea—Cisplatin—hematologic cancer	4.7e-05	0.000184	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IL2RA—hematologic cancer	4.66e-05	0.000286	CbGpPWpGaD
Cysteamine—Mental disorder—Doxorubicin—hematologic cancer	4.63e-05	0.000181	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2—hematologic cancer	4.63e-05	0.000284	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—hematologic cancer	4.61e-05	0.000283	CbGpPWpGaD
Cysteamine—Convulsion—Methotrexate—hematologic cancer	4.61e-05	0.00018	CcSEcCtD
Cysteamine—Vomiting—Etoposide—hematologic cancer	4.61e-05	0.00018	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—hematologic cancer	4.61e-05	0.00018	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—hematologic cancer	4.61e-05	0.00018	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—hematologic cancer	4.6e-05	0.00018	CcSEcCtD
Cysteamine—Agitation—Epirubicin—hematologic cancer	4.57e-05	0.000179	CcSEcCtD
Cysteamine—Dyspepsia—Prednisone—hematologic cancer	4.57e-05	0.000179	CcSEcCtD
Cysteamine—Rash—Etoposide—hematologic cancer	4.57e-05	0.000179	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—hematologic cancer	4.57e-05	0.000179	CcSEcCtD
Cysteamine—Headache—Etoposide—hematologic cancer	4.54e-05	0.000178	CcSEcCtD
Cysteamine—Tension—Doxorubicin—hematologic cancer	4.52e-05	0.000177	CcSEcCtD
Cysteamine—Decreased appetite—Prednisone—hematologic cancer	4.52e-05	0.000177	CcSEcCtD
Cysteamine—Rash—Prednisolone—hematologic cancer	4.51e-05	0.000176	CcSEcCtD
Cysteamine—Dermatitis—Prednisolone—hematologic cancer	4.5e-05	0.000176	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PDGFB—hematologic cancer	4.5e-05	0.000276	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.5e-05	0.000176	CcSEcCtD
Cysteamine—Fatigue—Prednisone—hematologic cancer	4.48e-05	0.000175	CcSEcCtD
Cysteamine—Headache—Prednisolone—hematologic cancer	4.48e-05	0.000175	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—hematologic cancer	4.47e-05	0.000175	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—hematologic cancer	4.47e-05	0.000175	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—IL2RA—hematologic cancer	4.47e-05	0.000275	CbGpPWpGaD
Cysteamine—Leukopenia—Epirubicin—hematologic cancer	4.46e-05	0.000174	CcSEcCtD
Cysteamine—Constipation—Prednisone—hematologic cancer	4.44e-05	0.000174	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—hematologic cancer	4.43e-05	0.000272	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TERT—hematologic cancer	4.42e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TSC2—hematologic cancer	4.4e-05	0.00027	CbGpPWpGaD
Cysteamine—Confusional state—Methotrexate—hematologic cancer	4.38e-05	0.000171	CcSEcCtD
Cysteamine—Dizziness—Triamcinolone—hematologic cancer	4.35e-05	0.00017	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—hematologic cancer	4.34e-05	0.00017	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—hematologic cancer	4.31e-05	0.000169	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDGFB—hematologic cancer	4.31e-05	0.000265	CbGpPWpGaD
Cysteamine—Nausea—Etoposide—hematologic cancer	4.3e-05	0.000168	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—hematologic cancer	4.3e-05	0.000168	CcSEcCtD
Cysteamine—Feeling abnormal—Prednisone—hematologic cancer	4.28e-05	0.000168	CcSEcCtD
Cysteamine—Asthenia—Dexamethasone—hematologic cancer	4.28e-05	0.000167	CcSEcCtD
Cysteamine—Asthenia—Betamethasone—hematologic cancer	4.28e-05	0.000167	CcSEcCtD
Cysteamine—Nervous system disorder—Methotrexate—hematologic cancer	4.26e-05	0.000167	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—hematologic cancer	4.26e-05	0.000167	CcSEcCtD
Cysteamine—Gastrointestinal pain—Prednisone—hematologic cancer	4.25e-05	0.000166	CcSEcCtD
Cysteamine—Nausea—Prednisolone—hematologic cancer	4.25e-05	0.000166	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—hematologic cancer	4.23e-05	0.000166	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR3—hematologic cancer	4.23e-05	0.00026	CbGpPWpGaD
Cysteamine—Skin disorder—Methotrexate—hematologic cancer	4.22e-05	0.000165	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TSC2—hematologic cancer	4.21e-05	0.000259	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.21e-05	0.000165	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MAPK14—hematologic cancer	4.19e-05	0.000257	CbGpPWpGaD
Cysteamine—Discomfort—Epirubicin—hematologic cancer	4.19e-05	0.000164	CcSEcCtD
Cysteamine—Vomiting—Triamcinolone—hematologic cancer	4.18e-05	0.000164	CcSEcCtD
Cysteamine—Rash—Triamcinolone—hematologic cancer	4.14e-05	0.000162	CcSEcCtD
Cysteamine—Dermatitis—Triamcinolone—hematologic cancer	4.14e-05	0.000162	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—hematologic cancer	4.14e-05	0.000162	CcSEcCtD
Cysteamine—Urticaria—Prednisone—hematologic cancer	4.13e-05	0.000161	CcSEcCtD
Cysteamine—Leukopenia—Doxorubicin—hematologic cancer	4.12e-05	0.000161	CcSEcCtD
Cysteamine—Headache—Triamcinolone—hematologic cancer	4.12e-05	0.000161	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ESR1—hematologic cancer	4.11e-05	0.000252	CbGpPWpGaD
Cysteamine—Body temperature increased—Prednisone—hematologic cancer	4.11e-05	0.000161	CcSEcCtD
Cysteamine—Abdominal pain—Prednisone—hematologic cancer	4.11e-05	0.000161	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—hematologic cancer	4.1e-05	0.00016	CcSEcCtD
Cysteamine—Diarrhoea—Dexamethasone—hematologic cancer	4.08e-05	0.00016	CcSEcCtD
Cysteamine—Diarrhoea—Betamethasone—hematologic cancer	4.08e-05	0.00016	CcSEcCtD
Cysteamine—Anaphylactic shock—Epirubicin—hematologic cancer	4.06e-05	0.000159	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FN1—hematologic cancer	4.06e-05	0.000249	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGFR3—hematologic cancer	4.05e-05	0.000249	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK14—hematologic cancer	4.01e-05	0.000247	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKBIA—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BAD—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—hematologic cancer	3.99e-05	0.000156	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—hematologic cancer	3.98e-05	0.000156	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—hematologic cancer	3.98e-05	0.000156	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NOTCH1—hematologic cancer	3.97e-05	0.000244	CbGpPWpGaD
Cysteamine—Skin disorder—Epirubicin—hematologic cancer	3.95e-05	0.000154	CcSEcCtD
Cysteamine—Dizziness—Betamethasone—hematologic cancer	3.94e-05	0.000154	CcSEcCtD
Cysteamine—Dizziness—Dexamethasone—hematologic cancer	3.94e-05	0.000154	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ESR1—hematologic cancer	3.94e-05	0.000242	CbGpPWpGaD
Cysteamine—Nausea—Triamcinolone—hematologic cancer	3.9e-05	0.000153	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.89e-05	0.000152	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CD80—hematologic cancer	3.89e-05	0.000239	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FN1—hematologic cancer	3.89e-05	0.000239	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—hematologic cancer	3.88e-05	0.000239	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—hematologic cancer	3.88e-05	0.000239	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NRAS—hematologic cancer	3.88e-05	0.000239	CbGpPWpGaD
Cysteamine—Discomfort—Doxorubicin—hematologic cancer	3.87e-05	0.000152	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—hematologic cancer	3.87e-05	0.000152	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—hematologic cancer	3.86e-05	0.000151	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NFKBIA—hematologic cancer	3.84e-05	0.000236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BAD—hematologic cancer	3.84e-05	0.000236	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisone—hematologic cancer	3.83e-05	0.00015	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—hematologic cancer	3.82e-05	0.00015	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTPN11—hematologic cancer	3.81e-05	0.000234	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH1—hematologic cancer	3.81e-05	0.000234	CbGpPWpGaD
Cysteamine—Vomiting—Dexamethasone—hematologic cancer	3.79e-05	0.000148	CcSEcCtD
Cysteamine—Vomiting—Betamethasone—hematologic cancer	3.79e-05	0.000148	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—hematologic cancer	3.79e-05	0.000148	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—hematologic cancer	3.77e-05	0.000148	CcSEcCtD
Cysteamine—Rash—Betamethasone—hematologic cancer	3.76e-05	0.000147	CcSEcCtD
Cysteamine—Rash—Dexamethasone—hematologic cancer	3.76e-05	0.000147	CcSEcCtD
Cysteamine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.76e-05	0.000147	CcSEcCtD
Cysteamine—Dermatitis—Dexamethasone—hematologic cancer	3.76e-05	0.000147	CcSEcCtD
Cysteamine—Dermatitis—Betamethasone—hematologic cancer	3.76e-05	0.000147	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.75e-05	0.000147	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—hematologic cancer	3.74e-05	0.000146	CcSEcCtD
Cysteamine—Headache—Betamethasone—hematologic cancer	3.74e-05	0.000146	CcSEcCtD
Cysteamine—Headache—Dexamethasone—hematologic cancer	3.74e-05	0.000146	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CD80—hematologic cancer	3.73e-05	0.000229	CbGpPWpGaD
Cysteamine—Asthenia—Prednisone—hematologic cancer	3.73e-05	0.000146	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—hematologic cancer	3.72e-05	0.000229	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KIT—hematologic cancer	3.72e-05	0.000229	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—hematologic cancer	3.72e-05	0.000229	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—hematologic cancer	3.72e-05	0.000228	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREB1—hematologic cancer	3.7e-05	0.000227	CbGpPWpGaD
Cysteamine—Nervous system disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTPN11—hematologic cancer	3.66e-05	0.000225	CbGpPWpGaD
Cysteamine—Skin disorder—Doxorubicin—hematologic cancer	3.65e-05	0.000143	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BRAF—hematologic cancer	3.65e-05	0.000224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—hematologic cancer	3.62e-05	0.000222	CbGpPWpGaD
Cysteamine—Somnolence—Epirubicin—hematologic cancer	3.61e-05	0.000141	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IL6R—hematologic cancer	3.61e-05	0.000222	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREBBP—hematologic cancer	3.6e-05	0.000221	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—hematologic cancer	3.58e-05	0.00014	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—hematologic cancer	3.58e-05	0.00014	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—hematologic cancer	3.58e-05	0.00014	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—hematologic cancer	3.56e-05	0.000219	CbGpPWpGaD
Cysteamine—Diarrhoea—Prednisone—hematologic cancer	3.55e-05	0.000139	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.55e-05	0.000139	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CREB1—hematologic cancer	3.54e-05	0.000218	CbGpPWpGaD
Cysteamine—Nausea—Dexamethasone—hematologic cancer	3.54e-05	0.000139	CcSEcCtD
Cysteamine—Nausea—Betamethasone—hematologic cancer	3.54e-05	0.000139	CcSEcCtD
Cysteamine—Decreased appetite—Epirubicin—hematologic cancer	3.53e-05	0.000138	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.51e-05	0.000137	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—hematologic cancer	3.5e-05	0.000137	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—BRAF—hematologic cancer	3.5e-05	0.000215	CbGpPWpGaD
Cysteamine—Constipation—Epirubicin—hematologic cancer	3.47e-05	0.000136	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCL2—hematologic cancer	3.47e-05	0.000213	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6R—hematologic cancer	3.46e-05	0.000212	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CREBBP—hematologic cancer	3.45e-05	0.000212	CbGpPWpGaD
Cysteamine—Urticaria—Methotrexate—hematologic cancer	3.45e-05	0.000135	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MAP2K1—hematologic cancer	3.44e-05	0.000211	CbGpPWpGaD
Cysteamine—Dizziness—Prednisone—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PIK3CD—hematologic cancer	3.41e-05	0.00021	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—hematologic cancer	3.38e-05	0.000208	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—hematologic cancer	3.35e-05	0.000131	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—KRAS—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Cysteamine—Somnolence—Doxorubicin—hematologic cancer	3.34e-05	0.000131	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.32e-05	0.00013	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—hematologic cancer	3.31e-05	0.000129	CcSEcCtD
Cysteamine—Vomiting—Prednisone—hematologic cancer	3.3e-05	0.000129	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—MAP2K1—hematologic cancer	3.29e-05	0.000202	CbGpPWpGaD
Cysteamine—Rash—Prednisone—hematologic cancer	3.27e-05	0.000128	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—hematologic cancer	3.27e-05	0.000201	CbGpPWpGaD
Cysteamine—Dermatitis—Prednisone—hematologic cancer	3.27e-05	0.000128	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF2—hematologic cancer	3.27e-05	0.000201	CbGpPWpGaD
Cysteamine—Decreased appetite—Doxorubicin—hematologic cancer	3.27e-05	0.000128	CcSEcCtD
Cysteamine—Headache—Prednisone—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—hematologic cancer	3.24e-05	0.000199	CbGpPWpGaD
Cysteamine—Fatigue—Doxorubicin—hematologic cancer	3.24e-05	0.000127	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—hematologic cancer	3.23e-05	0.000126	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PIK3R1—hematologic cancer	3.22e-05	0.000198	CbGpPWpGaD
Cysteamine—Constipation—Doxorubicin—hematologic cancer	3.21e-05	0.000126	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—hematologic cancer	3.21e-05	0.000126	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—hematologic cancer	3.21e-05	0.000126	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—hematologic cancer	3.2e-05	0.000197	CbGpPWpGaD
Cysteamine—Hypersensitivity—Methotrexate—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGF2—hematologic cancer	3.13e-05	0.000193	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JAK2—hematologic cancer	3.13e-05	0.000192	CbGpPWpGaD
Cysteamine—Asthenia—Methotrexate—hematologic cancer	3.11e-05	0.000122	CcSEcCtD
Cysteamine—Feeling abnormal—Doxorubicin—hematologic cancer	3.1e-05	0.000121	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PIK3R1—hematologic cancer	3.09e-05	0.00019	CbGpPWpGaD
Cysteamine—Nausea—Prednisone—hematologic cancer	3.09e-05	0.000121	CcSEcCtD
Cysteamine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.07e-05	0.00012	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CA—hematologic cancer	3.07e-05	0.000189	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—hematologic cancer	3.06e-05	0.000188	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JAK2—hematologic cancer	3e-05	0.000185	CbGpPWpGaD
Cysteamine—Hypersensitivity—Epirubicin—hematologic cancer	2.99e-05	0.000117	CcSEcCtD
Cysteamine—Urticaria—Doxorubicin—hematologic cancer	2.99e-05	0.000117	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MTOR—hematologic cancer	2.98e-05	0.000183	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—hematologic cancer	2.98e-05	0.000183	CbGpPWpGaD
Cysteamine—Abdominal pain—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—hematologic cancer	2.94e-05	0.000181	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—hematologic cancer	2.93e-05	0.00018	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—hematologic cancer	2.91e-05	0.000114	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—hematologic cancer	2.87e-05	0.000112	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—MTOR—hematologic cancer	2.85e-05	0.000175	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—hematologic cancer	2.85e-05	0.000175	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—hematologic cancer	2.84e-05	0.000175	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—hematologic cancer	2.79e-05	0.000172	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—hematologic cancer	2.78e-05	0.000109	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—hematologic cancer	2.77e-05	0.000108	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AKT1—hematologic cancer	2.76e-05	0.00017	CbGpPWpGaD
Cysteamine—Vomiting—Methotrexate—hematologic cancer	2.76e-05	0.000108	CcSEcCtD
Cysteamine—Rash—Methotrexate—hematologic cancer	2.74e-05	0.000107	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CASP3—hematologic cancer	2.74e-05	0.000168	CbGpPWpGaD
Cysteamine—Dermatitis—Methotrexate—hematologic cancer	2.73e-05	0.000107	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IL2—hematologic cancer	2.73e-05	0.000168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—hematologic cancer	2.72e-05	0.000167	CbGpPWpGaD
Cysteamine—Headache—Methotrexate—hematologic cancer	2.72e-05	0.000106	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL6—hematologic cancer	2.72e-05	0.000167	CbGpPWpGaD
Cysteamine—Asthenia—Doxorubicin—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—hematologic cancer	2.68e-05	0.000164	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—hematologic cancer	2.66e-05	0.000164	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—hematologic cancer	2.66e-05	0.000163	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—hematologic cancer	2.65e-05	0.000163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—hematologic cancer	2.62e-05	0.000161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—hematologic cancer	2.62e-05	0.000161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—hematologic cancer	2.61e-05	0.00016	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—hematologic cancer	2.58e-05	0.000101	CcSEcCtD
Cysteamine—Nausea—Methotrexate—hematologic cancer	2.58e-05	0.000101	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CDKN1A—hematologic cancer	2.58e-05	0.000158	CbGpPWpGaD
Cysteamine—Diarrhoea—Doxorubicin—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTEN—hematologic cancer	2.57e-05	0.000158	CbGpPWpGaD
Cysteamine—Rash—Epirubicin—hematologic cancer	2.56e-05	0.0001	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—hematologic cancer	2.56e-05	0.0001	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCND1—hematologic cancer	2.55e-05	0.000157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—hematologic cancer	2.55e-05	0.000157	CbGpPWpGaD
Cysteamine—Headache—Epirubicin—hematologic cancer	2.54e-05	9.96e-05	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MAPK8—hematologic cancer	2.51e-05	0.000155	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—hematologic cancer	2.51e-05	0.000154	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—hematologic cancer	2.49e-05	9.73e-05	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—hematologic cancer	2.47e-05	0.000152	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—hematologic cancer	2.46e-05	0.000151	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EP300—hematologic cancer	2.45e-05	0.000151	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—hematologic cancer	2.41e-05	9.44e-05	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—hematologic cancer	2.41e-05	0.000148	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—hematologic cancer	2.4e-05	0.000148	CbGpPWpGaD
Cysteamine—Vomiting—Doxorubicin—hematologic cancer	2.39e-05	9.35e-05	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SRC—hematologic cancer	2.38e-05	0.000146	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—hematologic cancer	2.37e-05	9.28e-05	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—hematologic cancer	2.37e-05	9.27e-05	CcSEcCtD
Cysteamine—Headache—Doxorubicin—hematologic cancer	2.35e-05	9.22e-05	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EP300—hematologic cancer	2.35e-05	0.000144	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—hematologic cancer	2.32e-05	0.000143	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—hematologic cancer	2.3e-05	0.000141	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—hematologic cancer	2.29e-05	0.000141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—hematologic cancer	2.29e-05	0.00014	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—hematologic cancer	2.23e-05	8.74e-05	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—hematologic cancer	2.23e-05	0.000137	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—hematologic cancer	2.2e-05	0.000135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—hematologic cancer	2.2e-05	0.000135	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—hematologic cancer	2.2e-05	0.000135	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—hematologic cancer	2.14e-05	0.000131	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—hematologic cancer	2.13e-05	0.000131	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—hematologic cancer	2.11e-05	0.000129	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—hematologic cancer	2.05e-05	0.000126	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—hematologic cancer	2.04e-05	0.000126	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—hematologic cancer	1.97e-05	0.000121	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—hematologic cancer	1.89e-05	0.000116	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—hematologic cancer	1.81e-05	0.000111	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—hematologic cancer	1.75e-05	0.000108	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—hematologic cancer	1.74e-05	0.000107	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—hematologic cancer	1.68e-05	0.000103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—hematologic cancer	1.68e-05	0.000103	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—hematologic cancer	1.61e-05	9.88e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—hematologic cancer	1.61e-05	9.87e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—hematologic cancer	1.54e-05	9.46e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—hematologic cancer	1.48e-05	9.1e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—hematologic cancer	1.42e-05	8.73e-05	CbGpPWpGaD
